Medical Device News Magazine

The Fifth Cardio-Vascular Revolution?

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Professor Sherif Sultan offers his thoughts on the NICE UK Guidelines (Medical Device News Magazine)Author: Prof Sherif Sultan, MD FRCS FACS PhD

 

  • Western Vascular Institute, Department of Vascular and Endovascular Surgery, University Hospital Galway, National University of Ireland Galway, Ireland.
  • Department of Vascular Surgery and Endovascular Surgery, Galway Clinic, Doughiska, Royal College of Surgeons in Ireland and the National University of Ireland Galway affiliated Hospital, Ireland.

The Fifth Cardio-Vascular Revolution? Artificial Intelligence and unsupervised Machine Learning and Role of the “COMENDA” physiCian, cOMputer ENgineer, DAta scientist!

 

The cardiovascular global workforce is undergoing a massive technological shift called the “Fifth Cardiovascular Revolution”. According to the World Economic Forum report, one-third of essential skillsets in 2025 will comprise technology skills not yet considered imperative to the job today.

As cardiovascular specialists and key opinion leaders, we must prepare to meet the technological demands and beyond. We must develop, deliver and learn how to survive the future of technology as innovators and early adaptors and lead through the “Fifth Cardiovascular Revolution”.

We have hands-on experience making artificial intelligence (AI), machine learning (ML), and Big Data Analysis (BDA) in healthcare drive real value and transform care delivery for patients and caregivers. AI raises the bar for the gold standard patient experience of personalized and frictionless healthcare journeys.

AI, ML, Deep Learning (DL), aided by Natural Language Processing (NLP), Computer Vision, Robotics, and Reinforcement Learning, all offer opportunities to improve cardiovascular healthcare delivery.

The primary aim is to predict cardiovascular morbidity and mortality accurately over time by exploiting AI and BDA technologies in a ‘what’ scenario rather than the ‘how’ one.  AI and BDA were employed to identify high-risk patients, with the more precise prediction for cardiovascular and oncologic medical emergencies accurately to age disease occurrence, relapse or transition into another disease state.

ML supervised and unsupervised techniques could be applied to identify patterns in medical images, videos, or structured medical records to classify, understand, and help diagnose various diseases.

DL allowed rapid advances in medical image processing and pattern recognition algorithms. The application of DL techniques in cardiopulmonary imaging led to early detection of lung nodules and the recognition of malignancy by analyzing large amounts of clinical data and medical imaging data. Moreover, the usage of deep convolutional neural networks (CNNs) to predict postoperative right ventricular failure is a sign of future diagnostics.

NLP is concerned with developing techniques and algorithms to process and analyze large amounts of unstructured textual data. The advances in ML and DL intrigued many NLP researchers to develop various automatic techniques to solve various tasks. NLP is behind many “intelligent” real-world applications that we interact with daily such as Google Translate, Siri, Gmail’s Smart Compose/Reply, Duolingo and Grammarly.

Healthcare providers who will not join the fifth cardiovascular revolution, alongside artificial intelligence programs, will lose their jobs over time.

AI and BDA will grant improved deployment of scarce healthcare resources with personalized precision medical patient management plans. It will inform and impact policies and guidelines. AI/ML/BDA will expedite clinical trials. Furthermore, AI had created a paradigm shift in “disease management,” from providers waiting for individuals to become sick and present with symptoms and signs to healthcare organizations increasingly focused on disease prevention by proactively monitoring healthy individuals, performing preventative and wellness interventions, and managing prevention and wellness for at-risk individuals. Such paradox is the aim of precision health models emphasized by ML, DL, and NLP.

Current medical education is antiquated, AI and BDA will pioneer a new division in medicine. This professional hybrid physician, part-computer engineer, and data scientist will increasingly embark on new roles and shift from “oracle” to “counsellor” to the “COMENDA” physiCian, cOMputer ENgineer, DAta scientist. In this AI and BDA – empowered workforce, the proficiency to decipher clinical problems together will become more important than the knowledge of each practitioner.

Academic clinical centres must acquire teams with expertise implementing AI products developed or pioneered by other institutions. Orchestrating the introduction of new specializations coming from data science and engineering within healthcare delivery will become a critical skill in itself.

We can foresee that AI and BDA technologies will extensively influence our cardiovascular clinical practice within five years and augment patient care efforts. Over time, human clinicians will gear toward job designs and tasks that allow for uniquely human skills like empathy, persuasion and bigger-picture int

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”